Abbott Laboratories (ABT)

NYSE


Symbol		Exchange		Currency
ABT	·	NYSE	·	USD	Real-time
0Q15	·	London	·	USD	Real-time
ABT	·	Xetra	·	EUR	Delayed
ABT	·	Switzerland	·	CHF	Delayed
1ABT	·	Milan	·	EUR	Real-time
ABT	·	Vienna	·	EUR	Real-time
ABTm	·	Buenos Aires	·	ARS	Delayed
ABTCL	·	Santiago	·	CLP	Delayed
ABTT34	·	B3	·	BRL	Delayed
ABT	·	Mexico	·	MXN	Delayed
ABTUS	·	Lima	·	USD	Delayed
ABT	·	Frankfurt	·	EUR	Delayed
ABT	·	TradeGate	·	EUR	Delayed
ABT_KZ	·	KASE	·	USD	Delayed
ABT	·	BIVA	·	MXN	Delayed

Currency in USD

ABT Pro Research

96.89

+0.20(+0.20%)

Real-time Data·11:58:43

Fair Value

Unlock Value

Day's Range

95.06

97.53

52 wk Range

81.97

135.37

ABT Income Statement

Assess the Abbott income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the ABT net worth.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

43,075

43,653

40,109

41,950

44,328

Total Revenues Growth

aa.aa

+24.47%

+1.34%

-8.12%

+4.59%

+5.67%

Cost Of Revenues

aa.aa

18,080

19,083

17,919

18,644

19,210

Gross Profit

aa.aa

24,995

24,570

22,190

23,306

25,118

Gross Profit Growth

aa.aa

+27.49%

-1.7%

-9.69%

+5.03%

+7.77%

Gross Profit Margin %

aa.aa

58.03%

56.28%

55.32%

55.56%

56.66%

Other Operating Expenses, Total

aa.aa

15,791

15,457

14,970

15,810

16,201

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+11.65%	-2.12%	-3.15%	+5.61%	+2.47%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	2,738	2,741	2,619	2,823	2,889
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	11,006	10,703	10,385	11,109	11,630
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

9,204

9,113

7,220

7,496

8,917

Operating Income Growth

aa.aa

+68.51%

-0.99%

-20.77%

+3.82%

+18.96%

EBIT Margin %

aa.aa

21.37%

20.88%

18%

17.87%

20.12%

Net Interest Expenses

aa.aa

-490

-375

-252

-215

-185

Net Interest Expenses Growth

aa.aa

+2%

+23.47%

+32.8%

+14.68%

+13.95%

Interest Expense, Total

aa.aa

-533

-558

-637

-559

-493

Interest And Investment Income

aa.aa

183

385

344

308

Other Non Operating Expenses, Total

aa.aa

-87

-60

EBT, Excl. Unusual Items

aa.aa

8,720

8,651

6,908

7,285

8,740

Gain (Loss) On Sale Of Assets

aa.aa

-143

Other Unusual Items, Total

aa.aa

-111

-100

EBT, Incl. Unusual Items

aa.aa

8,211

8,306

6,664

7,013

8,466

EBT, Incl. Unusual Items Growth

aa.aa

+65.28%

+1.16%

-19.77%

+5.24%

+20.72%

EBT, Incl. Unusual Items Margin

aa.aa

19.06%

19.03%

16.61%

16.72%

19.1%

Income Tax Expense

aa.aa

1,140

1,373

941

-6,389

1,942

Net Income to Company

aa.aa

7,071

6,933

5,723

13,402

6,524

Minority Interest

aa.aa

Net Income

aa.aa

7,071

6,933

5,723

13,402

6,524

Net Income Growth

aa.aa

+57.31%

-1.95%

-17.45%

+134.18%

-51.32%

Net Income Margin %

aa.aa

16.42%

15.88%

14.27%

31.95%

14.72%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

7,042

6,905

5,700

13,400

6,500

Basic EPS - Continuing Operations

aa.aa

3.97

3.94

3.28

7.7

3.73

Basic EPS - Continuing Operations Growth

aa.aa

+58.1%

-0.71%

-16.83%

+135.09%

-51.52%

Diluted EPS - Continuing Operations

aa.aa

3.94

3.91

3.26

7.64

3.72

Diluted EPS - Continuing Operations Growth

aa.aa

+58.23%

-0.76%

-16.62%

+134.36%

-51.31%

Basic Weighted Average Shares Outstanding

aa.aa

1,775

1,753

1,740

1,741

Diluted Weighted Average Shares Outstanding

aa.aa

1,789

1,764

1,749

1,748

Dividend Per Share

aa.aa

1.82

1.92

2.08

2.24

2.4

Dividend Per Share Growth

aa.aa

+18.95%

+5.49%

+8.33%

+7.69%

+7.14%

EBITDA

aa.aa

12,742

12,380

10,463

10,714

12,033

EBITDA Growth

aa.aa

+44.98%

-2.84%

-15.48%

+2.4%

+12.31%

EBITDA Margin %

aa.aa

29.58%

28.36%

26.09%

25.54%

27.15%

EBIT

aa.aa

9,204

9,113

7,220

7,496

8,917

* In Millions of USD (except for per share items)

FAQ

What was Abbott’s revenue at year end?

At the end of the last reported fiscal year, Abbott (ABT) recorded total revenue of 44,328.00 million USD.

How much revenue did Abbott report in the most recent quarter?

In its most recent quarterly earnings report, Abbott posted revenue of 12,593.00 million USD.

What was Abbott’s net income for the year?

For the full year, Abbott reported net income of 6,524.00 million USD.

How much net income did Abbott post in the last quarter?

In the most recent quarter, Abbott (ABT) posted net income of 928.00 million USD.

What was Abbott’s gross profit for the year?

Gross profit for the year was reported at 25,118.00 million USD.

How much gross profit did Abbott generate last quarter?

Abbott recorded gross profit of 7,268.00 million USD in its latest quarterly report.

What was Abbott’s annual operating income?

For the full year, Abbott (ABT) reported operating income of 8,917.00 million USD.

What was Abbott’s operating income last quarter?

Quarterly operating income was 1,852.00 million USD.

What was Abbott’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 2,912.00 million USD.

What was the quarter-over-quarter change in EBITDA for Abbott?

EBITDA changed by 26.22% million USD compared to the last quarter.

What is Abbott’s most recent gross profit margin?

The latest reported gross profit margin for Abbott (ABT) is 57.71% million USD.

What is Abbott’s most recent net income margin?

Net income margin based on recent financials is 7.37% million USD.

What is Abbott’s most recent EBIT margin?

Abbott reported an EBIT margin of 14.71% million USD based on current figures.

How did Abbott’s revenue change compared to the previous quarter?

Revenue changed by 12.80% million USD compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Abbott?

In the latest quarter, gross profit changed by 15.84% million USD from the previous quarter.

S&P/TSX

35,349.56

+194.80

+0.55%

S&P/TSX 60

2,080.87

+11.73

+0.57%

US 30

51,089.90

+162.6

+0.32%

US 500

7,719.10

+52.4

+0.68%

S&P 500 VIX

15.69

-0.70

-4.27%

DAX

25,248.60

+309.25

+1.24%

Dollar Index

101.685

-0.198

-0.19%

Market Movers

Name	Last	Chg. %	Vol.
Toronto Dominion Bank	167.19	-0.12%	1.93M
TC Energy	83.46	+0.06%	1.93M
RBC	278.48	+0.22%	475.65K
Shopify Inc	216.00	+1.84%	593.88K
Thomson Reuters	141.77	+0.16%	804.63K
Bank of Nova Scotia	129.41	+0.30%	778.32K
Enbridge	65.34	-0.65%	1.49M

Name	Last	Chg. %	Vol.
Sayward Capital	0.04	+100.00%	1.00K
OCAL Financial	0.15	+57.89%	64.88K
Zeb Nickel	0.15	+50.00%	29.82K
Encanto Potash	0.070	+40.00%	52.48K
Adyton Resources	0.44	+39.68%	1.00K
Dye & Durham	1.35	+36.36%	933.88K
TinOne Resources	0.20	+37.93%	30.00K

Name	Last	Chg. %	Vol.
Element Lifestyle Retirement	0.0050	-50.00%	1.25K
Altiplano Metals	0.0100	-33.33%	124.00K
Ostrom Climate Solutions	0.0250	-28.57%	1.00K
RT Minerals	0.0250	-28.57%	293.00K
Principal Tech	0.23	-28.13%	5.00K
Western Gold Exploration	0.15	-25.00%	1.50K
Nextech3D.AI	0.070	-17.65%	1.00K

Trending Stocks

Name	Last	Chg. %	Vol.
TELUS	11.61	-0.17%	1.73M
BCE Inc	28.51	+0.56%	1.08M
Toronto Dominion Bank	167.19	-0.12%	1.93M
Celestica Inc.	550.90	+3.74%	156.08K
Air Canada	25.47	-3.12%	1.26M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaaaaaaaaa	28.11	+78.30%	49.93
A Aaa	16.15	+76.70%	28.54
Aaaaaa	16.00	+57.44%	25.19
Aaaaaaaaaa Aaaaa	16.81	+56.27%	26.32
Aaaaa Aa A Aa Aaaaa	2.2800	+54.43%	3.5210
Aa Aaa A	111.60	+51.70%	169.47
Aaaa Aa Aaa	31.49	+50.04%	47.43

Name	Last	Upside	Fair Value
Aaaaaaaaaaaaaaa	28.11	+78.30%	49.93
A Aaa	16.15	+76.70%	28.54
Aaaaaa	16.00	+57.44%	25.19
Aaaaaaaaaa Aaaaa	16.81	+56.27%	26.32
Aaaaa Aa A Aa Aaaaa	2.2800	+54.43%	3.5210
Aa Aaa A	111.60	+51.70%	169.47
Aaaa Aa Aaa	31.49	+50.04%	47.43

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Abbott Laboratories (ABT)

ABT Income Statement

FAQ

What was Abbott’s revenue at year end?

How much revenue did Abbott report in the most recent quarter?

What was Abbott’s net income for the year?

How much net income did Abbott post in the last quarter?

What was Abbott’s gross profit for the year?

How much gross profit did Abbott generate last quarter?

What was Abbott’s annual operating income?

What was Abbott’s operating income last quarter?

What was Abbott’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Abbott?

What is Abbott’s most recent gross profit margin?

What is Abbott’s most recent net income margin?

What is Abbott’s most recent EBIT margin?

How did Abbott’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Abbott?

Trending Stocks